ArticleInvestigational new drugs2010

Phase I trial of weekly docetaxel, weekly doxorubicin, daily oral cyclophosphamide, and G-CSF (ConTAC regimen) in advanced malignancies.

Robert Wesolowski et al.PubMed ↗Publisher ↗

No numbers read from the abstract.